Increasing Demand For Monoclonal Antibodies To Drive The Growth Of Protein A Resin Market

The global Protein A Resin Market is estimated to be valued at US$ 656.9 Mn in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Protein A resin is a sepharose-based chromatography material used for monoclonal antibody (mAb) purification. It relies on its ability to selectively and reversibly bind immunoglobulin G (IgG) from serum or cell culture supernatants. Protein A resin is commonly used in downstream processing during manufacturing of therapeutic mAbs for treatment of various medical conditions like cancer, arthritis, and autoimmune diseases. Its high selectivity and binding capacity make it ideal for purifying antibodies from complex mixtures during biopharmaceutical manufacturing.

Market key trends:

One of the key trends in the protein A resin market is the growing demand for monoclonal antibody therapies. Monoclonal antibodies have revolutionized treatment of various diseases and many new monoclonal antibody drugs are in clinical trials or under development. According to a report by BCC Research, the global monoclonal antibodies market is expected to grow at a CAGR of 9% during 2022-2027. As more monoclonal antibody therapies get approved and commercialized, it will drive the demand for protein A resins used in their downstream purification process. Additionally, expansion of biopharmaceutical contract manufacturing capabilities is also fueling market growth by increasing production volumes of biologics like monoclonal antibodies.

Porter’s Analysis

Threat of new entrants: Low as protein A resins require huge investments and there are already major well-established players in the market with significant experience and resources.
Bargaining power of buyers: Moderate as large biopharmaceutical companies can bargain on price due to bulk purchasing power but others have limited bargaining power.
Bargaining power of suppliers: Moderate as there are multiple suppliers for raw materials required to manufacture protein A resins.
Threat of new substitutes: Low as protein A resins have proven affinity and specificity for antibodies purification which is difficult to be replicated by substitutes.
Competitive rivalry: High as major players compete intensely on pricing, quality and innovation to cater to growing demand.

Key Takeaways

The Global Protein A Resin Market Demand  is expected to witness high growth, exhibiting CAGR of 8.5% over the forecast period, due to increasing demand for therapeutic monoclonal antibodies.

Regional analysis: North America is currently the largest as well as the fastest growing market for protein A resins owing to presence of major biopharmaceutical companies and growing R&D investments in the region. The Asia Pacific market is projected to witness highest growth during the forecast period supported by expansion of biologics manufacturing capabilities in countries like China and India.

Key players: Key players operating in the Protein A Resin market are GE Healthcare, Thermo Fisher Scientific, Repligen, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd. GE Healthcare held the highest market share in 2021 attributed to their innovative MabSelect resins. However, the market is expected to witness high competition with new product launches and expansion strategies by players.

Read More - https://www.pressreleasebulletin.com/protein-a-resin-market-size-and-analysis-trends-share-growth-and-demand-forecast/